Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
With two COVID-19 vaccines gaining emergency use approvals, mRNA technology has come into focus over the past year. RNA technology encompasses a wide range of modalities and RNA editing is one among them. Although the technique is still being perfected and hasn’t become clinically viable, its high efficiency and safety over DNA editing is expected to make a splash in the near future.
We interviewed Professor Toshifumi Tsukahara, an expert in RNA editing to know more about the current challenges and future opportunities in the field.
We interviewed Professor Toshifumi Tsukahara, an expert in RNA editing to know more about the current challenges and future opportunities in the field.